Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Emergence Delirium × Midazolam × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Prostatic Neoplasms 2 Skin Neoplasms 1 Sedation 1 Respiratory Aspiration 1 Respiration Disorders 1 Rectal Neoplasms 1 Rare Diseases 1 Pain 1 Neoplasms 1 Lung Neoplasms 1 Glioma 1 Emergence Delirium 1 Diverticulosis, Colonic 1 Cough 1 Colonic Neoplasms 1 Carcinoma, Squamous Cell 1 Carcinoma, Basal Cell 1 Breast Neoplasms 1 Anxiety Disorders 1 Agnosia 1

Interventions

Dexmedetomidine 3 Saline Solution 2 Propofol 2 remimazolam 1 Sufentanil 1 Ropivacaine 1 Midazolam 1 Methylene Blue 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05466279 2024-01-25

The Role of Remazolam in Reducing the Incidence of Postoperative Delirium in Elderly Patients

Zhejiang Cancer Hospital

Phase NA Completed

Emergence Delirium

Data powered by HemOnc (CC BY 4.0) Colophon ⚡